Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Cephalon (UK) Limited
Alton House, 4 Herbert Street, Dublin 2, Ireland
Telephone: +44 (0)1462 458 974
Fax: +44 (0)1462 450 755
Medical Information e-mail: medinfo@flynnpharma.com
Customer Care direct line: +44(0)1773 510 123

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 11/04/2011
PIL Actiq

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 11/04/2011 and displayed until Current
Reasons for adding or updating:
  • Change to manufacturer contact details
Updated on 01/03/2011 and displayed until 11/04/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 02/11/2010 and displayed until 01/03/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 09/04/2009 and displayed until 02/11/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
  • PIL Retired pending re-submission
Updated on 09/01/2009 and displayed until 09/04/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/04/2008 and displayed until 09/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 11/03/2008 and displayed until 24/04/2008
Reasons for adding or updating:
  • Change to MA holder contact details
  • Improved Electronic Presentation
Updated on 25/09/2007 and displayed until 11/03/2008
Reasons for adding or updating:
  • Change of licence holder
Updated on 26/09/2006 and displayed until 25/09/2007
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to warnings or special precautions for use
  • Change to date of revision
Updated on 09/01/2006 and displayed until 26/09/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
  • Change to storage instructions
Updated on 31/07/2003 and displayed until 09/01/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  fentanyl citrate